Showing results (231-240 of 390) with videos related to

Sort By:
Pageof 39
Nuclear Medicine Communications|January 4, 2023
Kidney absorbed radiation doses for [ 177 Lu]Lu-PSMA-617 and [ 177 Lu]Lu-PSMA-I&T determined by 3D clinical dosimetryMaike J M Uijen, Bastiaan M Privé, Carla M L van Herpen, et al.
Acta Neuropathologica Communications|April 10, 2014
Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitorHeidi Vn Küsters-Vandevelde, Annelieke Ecab Willemsen, Patricia Jta Groenen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxelTessa M Bosch, Alwin D R Huitema, Valerie D Doodeman, et al.
Head & Neck|March 27, 2015
Toxicity and efficacy of accelerated radiotherapy with concurrent weekly cisplatin for locally advanced head and neck carcinomaChantal M L Driessen, Geert O Janssens, Winette T A van der Graaf, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2016
Positron emission tomography response criteria in solid tumours criteria for quantitative analysis of [18F]-fluorodeoxyglucose positron emission tomography with integrated computed tomography for treatment response assessment in metastasised solid tumours: All that glitters is not goldAnnelieke E C A B Willemsen, Myrella Vlenterie, Carla M L van Herpen, et al.
Head & Neck|December 12, 2018
Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapyChantal M L Driessen, Joop Leijendeckers, Ad Snik, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 16, 2020
Informal caregiver well-being during and after patients' treatment with adjuvant chemotherapy for colon cancer: a prospective, exploratory studyS M C H Langenberg, H Poort, A N M Wymenga, et al.
Orphanet Journal of Rare Diseases|June 2, 2021
Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional surveyEline de Heus, Vivian Engelen, Irene Dingemans, et al.
International Immunopharmacology|February 1, 2021
Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestaneAnnelieke E C A B Willemsen, Xuehui He, Bram van Cranenbroek, et al.
BMC Immunology|December 19, 2012
Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndromeHetty Prinsen, I Jolanda M de Vries, Ruurd Torensma, et al.
Pageof 39